The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion

November 24, 2025 updated by: Mohamed Atef Ahmed, Sohag University
To evaluate the correlation between preoperative ultrasound imaging findings by 3D Color Doppler Ultrasound and the intraoperative severity of Placenta Accreta Spectrum (PAS) disorders, in order to assess the diagnostic accuracy of sonographic markers and their utility in predicting the extent of placental invasion.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Faculty of medecine Sohag university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: Pregnant women with clinical or ultrasound suspicion of PAS, including:

  1. Placenta previa or low-lying placenta

  2. History of previous cesarean section(s) or uterine surgery (e.g., myomectomy, D&C) 2. Gestational age ≥ 28 weeks at the time of ultrasound evaluation 3. Undergoing planned cesarean delivery in the study hospital 4. Availability of preoperative ultrasound imaging performed using a standardized protocol.

    5. Patient can provide informed Written consent and Agree to participate in the study

    -

    Exclusion Criteria: Patients with incomplete or poor-quality ultrasound data 2. Unavailability of intraoperative confirmation of placental invasion 3. Patients with placental abruption or other causes of acute bleeding requiring emergency delivery without imaging 4. Loss to follow-up prior to delivery 5. Declined consent or withdrew participation from the study

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Ultrasonography
Procedure: Cesarian section
Cesarian section for detection the degree of placenta Accreta spectrum invasion comparaple to 3D color Doppler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Correlation between preoperative ultrasound findings and the confirmed degree of Placenta Accreta Spectrum (PAS) severity (classified as accreta, increta, or percreta). o The classification will be based on intraoperative surgical findings.
Time Frame: Patient preg 28 wks compare finding intraoperative
Patient preg 28 wks compare finding intraoperative
Correlation between preoperative ultrasound findings and the confirmed degree of Placenta Accreta Spectrum (PAS) severity (classified as accreta, increta, or percreta). o The classification will be based on intraoperative surgical findings.
Time Frame: Pt preg for more than 28wks preg and compare finding intraoperative
Pt preg for more than 28wks preg and compare finding intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2025

Primary Completion (Actual)

September 10, 2025

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

September 30, 2025

First Submitted That Met QC Criteria

November 24, 2025

First Posted (Actual)

November 26, 2025

Study Record Updates

Last Update Posted (Actual)

November 26, 2025

Last Update Submitted That Met QC Criteria

November 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-med-25-8____12MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placenta Accrete Spectrum

Clinical Trials on Cesarian section

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe